ATOS - Company ID 0001488039
The table below shows ATOSSA THERAPEUTICS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.09M | $31.72M | $51.84M | $57.86M | $65.12M | $74.77M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $31.01M |
| $36.67M |
| $55.68M |
| $62.52M |
| $68.74M |
| $77.11M |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | - | - | - | - | - | - |
| Total assets | $32.28M | $37.94M | $58.01M | $64.52M | $70.75M | $79.48M |
| Accounts payable | $1.98M | $2.57M | $3.54M | $2.01M | $1.17M | $1.56M |
| Total current liabilities | $5.45M | $7.46M | $8.22M | $6.82M | $5.42M | $5.80M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $5.45M | $7.46M | $8.22M | $6.82M | $5.42M | $5.80M |
| Retained earnings | -$264.64M | -$256.15M | -$235.63M | -$226.93M | -$218.51M | -$205.44M |
| Total equity | $26.83M | $30.49M | $49.79M | $57.70M | $65.32M | $73.68M |